Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Acute Lung Injury D055371 33 associated lipids
Mucositis D052016 7 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Atherosclerosis D050197 85 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Hyperuricemia D033461 4 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Fetal Weight D020567 12 associated lipids
Stroke D020521 32 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Migraine without Aura D020326 1 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Venous Thrombosis D020246 11 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Leukostasis D018921 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Pelvic Pain D017699 7 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Liver Failure D017093 5 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Steel HC et al. Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant-activated human neutrophils: a potential strategy to control neutrophil-mediated inflammation. 2009 J. Antimicrob. Chemother. pmid:19744985
Cook VL et al. The effect of lidocaine on in vitro adhesion and migration of equine neutrophils. 2009 Vet. Immunol. Immunopathol. pmid:19136156
Musio S et al. Anaphylaxis to a self-peptide in the absence of mast cells or histamine. 2009 Lab. Invest. pmid:19188909
Welch EJ et al. Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation. 2009 Mol. Pharmacol. pmid:18931035
McIntyre TM et al. The emerging roles of PAF acetylhydrolase. 2009 J. Lipid Res. pmid:18838739
Liu J et al. New vernocuminosides from the stem barks of Vernonia cumingiana Benth. 2009 Steroids pmid:18840454
Brooks AC et al. Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases. 2009 J. Vet. Pharmacol. Ther. pmid:19290950
Rehse K et al. New 1H-pyrazole-4-carboxamides with antiplatelet activity. 2009 Arch. Pharm. (Weinheim) pmid:19051198
Ereso AQ et al. Lipoxin a(4) attenuates microvascular fluid leak during inflammation. 2009 J. Surg. Res. pmid:19524267
Detopoulou P et al. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure. 2009 Clin. Biochem. pmid:18955040
Giannattasio G et al. Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesis. 2009 Biochim. Biophys. Acta pmid:19130898
Khodoun M et al. Peanuts can contribute to anaphylactic shock by activating complement. 2009 J. Allergy Clin. Immunol. pmid:19121857
Plager DA et al. Pimecrolimus reduces eosinophil activation associated with calcium mobilization. 2009 Int. Arch. Allergy Immunol. pmid:19127068
Severino DN et al. Edematogenic activity of scorpion venoms from the Buthidae family and the role of platelet-activating factor and nitric oxide in paw edema induced by Tityus venoms. 2009 Inflammation pmid:19096919
Mukai K et al. New insights into the roles for basophils in acute and chronic allergy. 2009 Allergol Int pmid:19153532
Eigenmann PA Mechanisms of food allergy. 2009 Pediatr Allergy Immunol pmid:19154253
Penna C et al. Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor. 2009 Acta Physiol (Oxf) pmid:19432589
Dutra PM et al. Stimulation of Leishmania tropica protein kinase CK2 activities by platelet-activating factor (PAF). 2009 Acta Trop. pmid:19433049
Cheng L et al. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. 2009 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19389802
Di Leo E et al. Treatment of acquired cold urticaria with rupatadine. 2009 Allergy pmid:19392988
Chang W et al. Common pathways for activation of proinflammatory gene expression by G protein-coupled receptors in primary lung epithelial and endothelial cells. 2009 Exp. Lung Res. pmid:19415549
Yamamura K et al. Intracellular protein phosphorylation in eosinophils and the functional relevance in cytokine production. 2009 Int. Arch. Allergy Immunol. pmid:19494504
Dorfman AL et al. The effect of oxygen and light on the structure and function of the neonatal rat retina. 2009 Doc Ophthalmol pmid:18483821
Keating FK and Schneider DJ The influence of platelet activating factor on the effects of platelet agonists and antiplatelet agents in vitro. 2009 J. Thromb. Thrombolysis pmid:18574670
Zhang X et al. Effect of baicalin on inflammatory mediator levels and microcirculation disturbance in rats with severe acute pancreatitis. 2009 Pancreas pmid:19657312
Zhang Q et al. Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia. 2009 J. Invest. Dermatol. pmid:18580961
Guo CJ et al. The synthesis and biological evaluation of 10-O-dialkylaminoethyl ginkgolide B as platelet-activating factor antagonist. 2008 Sep-Oct J Asian Nat Prod Res pmid:19003620
Kurdiumov IN et al. [Cerebrovascular and antiaggregative effects of GABA-docosahexaenoyldopamine conjugate]. 2008 Jul-Aug Eksp Klin Farmakol pmid:18819437
Chamogeorgakis TP et al. Effect of N-acetyl-L-cysteine on lung ischaemia reperfusion injury in a porcine experimental model. 2008 Jan-Feb ANZ J Surg pmid:18199211
Kikuchi M et al. Platelet-activating factor (PAF) increases NO production in human endothelial cells-real-time monitoring by DAR-4M AM. 2008 Apr-May Prostaglandins Leukot. Essent. Fatty Acids pmid:18502110
Kono N et al. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. 2008 J. Biol. Chem. pmid:18024956
Kuliszkiewicz-Janus M et al. Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia--a 31P MRS in vitro study. 2008 Cell. Mol. Biol. Lett. pmid:17952375
Bélanger C et al. Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats. 2008 Immunology pmid:18217950
Figueiredo MB et al. Blockades of phospholipase A(2) and platelet-activating factor receptors reduce the hemocyte phagocytosis in Rhodnius prolixus: in vitro experiments. 2008 J. Insect Physiol. pmid:18036540
Adamson RH et al. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18178724
Gountopoulou A et al. TNFalpha is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K. 2008 Cytokine pmid:18180165
Kwasniewski FH et al. Small bowel injury associated to allergy is triggered by platelet-activating factor, mast cells, neutrophils and protected by nitric oxide. 2008 Int. Immunopharmacol. pmid:18182253
Morita K et al. Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate-NO-cyclic GMP signalling in spinal cord in mice. 2008 Pain pmid:18353555
Simonenko VB et al. [Losartan for the correction of thrombocyte activity in patients suffering from arterial hypertension with metabolic syndrome]. 2008 Klin Med (Mosk) pmid:18326282
Harayama T et al. Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor. 2008 J. Biol. Chem. pmid:18285344
Mizutani T et al. Genuine functions of P-glycoprotein (ABCB1). 2008 Curr. Drug Metab. pmid:18288958
Fukunaga A et al. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. 2008 J. Immunol. pmid:18292528
Lu J et al. Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18356536
Ryan SD et al. Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. 2008 J. Lipid Res. pmid:18550892
Jiang Y et al. Three-dimensional localization and quantification of PAF-induced gap formation in intact venular microvessels. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18515648
Su J et al. Natural antibodies against phosphorylcholine as potential protective factors in SLE. 2008 Rheumatology (Oxford) pmid:18522961
McLaughlin NJ et al. Platelet-activating factor-mediated endosome formation causes membrane translocation of p67phox and p40phox that requires recruitment and activation of p38 MAPK, Rab5a, and phosphatidylinositol 3-kinase in human neutrophils. 2008 J. Immunol. pmid:18523285
Felfernig M et al. Molecular weight of hydroxyethyl starch molecules influences coagulation profile measured by thrombelastography. 2008 J R Nav Med Serv pmid:18524134
Tsoupras AB et al. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? 2008 AIDS Res. Hum. Retroviruses pmid:18620493
Corl CM et al. Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells. 2008 J. Dairy Sci. pmid:18650283